BRPI0510328A - macrolìdeos ligados a éster úteis para o tratamento de infecções microbianas - Google Patents

macrolìdeos ligados a éster úteis para o tratamento de infecções microbianas

Info

Publication number
BRPI0510328A
BRPI0510328A BRPI0510328-2A BRPI0510328A BRPI0510328A BR PI0510328 A BRPI0510328 A BR PI0510328A BR PI0510328 A BRPI0510328 A BR PI0510328A BR PI0510328 A BRPI0510328 A BR PI0510328A
Authority
BR
Brazil
Prior art keywords
ester
treatment
microbial infections
useful
linked
Prior art date
Application number
BRPI0510328-2A
Other languages
English (en)
Inventor
Sulejman Alihodzic
Stjepan Mutak
Drazen Pavlovic
Ivana Palej
Vlado Stimac
Samra Kapic
Adrijana Zupan
Maja Matanovic Skugor
Original Assignee
Glaxosmithkline Zagreb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Zagreb filed Critical Glaxosmithkline Zagreb
Publication of BRPI0510328A publication Critical patent/BRPI0510328A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

MACROLìDEOS LIGADOS A éSTER úTEIS PARA O TRATAMENTO DE INFECçõES MICROBIANAS. A presente invenção relaciona-se aos macrolídeos de 14 ou 15 elementos, substituídos na posição 4, de fórmula (1) , e aos seus derivados farmaceuticamente aceitáveis, aos processos para a sua preparação e ao seu uso na terapia ou na profilaxia de infecções microbianas sistêmicas ou tópicas em um corpo humano ou animal.
BRPI0510328-2A 2004-05-06 2005-05-02 macrolìdeos ligados a éster úteis para o tratamento de infecções microbianas BRPI0510328A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56940204P 2004-05-06 2004-05-06
US58111804P 2004-06-18 2004-06-18
PCT/IB2005/001186 WO2005108412A1 (en) 2004-05-06 2005-05-02 Ester linked macrolides useful for the treatment of microbial infections

Publications (1)

Publication Number Publication Date
BRPI0510328A true BRPI0510328A (pt) 2007-10-23

Family

ID=34967616

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510328-2A BRPI0510328A (pt) 2004-05-06 2005-05-02 macrolìdeos ligados a éster úteis para o tratamento de infecções microbianas

Country Status (16)

Country Link
US (1) US20080255060A1 (pt)
EP (1) EP1756135B1 (pt)
JP (1) JP2007536371A (pt)
AR (1) AR049269A1 (pt)
AT (1) ATE439367T1 (pt)
AU (1) AU2005240849B2 (pt)
BR (1) BRPI0510328A (pt)
CA (1) CA2566085A1 (pt)
DE (1) DE602005015963D1 (pt)
ES (1) ES2331739T3 (pt)
IL (1) IL178876A0 (pt)
MA (1) MA28640B1 (pt)
MX (1) MXPA06012923A (pt)
NO (1) NO20065662L (pt)
RU (1) RU2006143051A (pt)
WO (1) WO2005108412A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2529817C (en) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
EP1879903A1 (en) 2005-05-10 2008-01-23 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Ether linked macrolides useful for the treatment of microbial infections
CN101917850B (zh) 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
WO2010048599A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Methods for treating gastrointestinal diseases
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
US9051346B2 (en) * 2010-05-20 2015-06-09 Cempra Pharmaceuticals, Inc. Process for preparing triazole-containing ketolide antibiotics
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
SG11201405895UA (en) 2012-03-27 2014-10-30 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
US9861616B2 (en) 2013-03-14 2018-01-09 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
JP6675973B2 (ja) 2013-03-15 2020-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド抗菌薬を調製するための集束的な方法
GB201608236D0 (en) 2016-05-11 2016-06-22 Fidelta D O O Seco macrolide compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds
SI1628989T1 (sl) * 2003-05-13 2007-06-30 Glaxo Group Ltd Nove cikliäśne spojine s 14 in 15 obroäśnimi äśleni
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310979D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
EP1879903A1 (en) * 2005-05-10 2008-01-23 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Ether linked macrolides useful for the treatment of microbial infections

Also Published As

Publication number Publication date
AU2005240849B2 (en) 2008-10-23
IL178876A0 (en) 2007-03-08
NO20065662L (no) 2007-01-16
AU2005240849A1 (en) 2005-11-17
CA2566085A1 (en) 2005-11-17
EP1756135B1 (en) 2009-08-12
JP2007536371A (ja) 2007-12-13
MA28640B1 (fr) 2007-06-01
MXPA06012923A (es) 2007-07-18
DE602005015963D1 (de) 2009-09-24
US20080255060A1 (en) 2008-10-16
AR049269A1 (es) 2006-07-12
ATE439367T1 (de) 2009-08-15
ES2331739T3 (es) 2010-01-14
RU2006143051A (ru) 2008-06-20
WO2005108412A1 (en) 2005-11-17
EP1756135A1 (en) 2007-02-28

Similar Documents

Publication Publication Date Title
BRPI0510328A (pt) macrolìdeos ligados a éster úteis para o tratamento de infecções microbianas
BR0116431A (pt) Antibióticos de macrolìdeos
RS41904A (en) Macrolides
BR0316169A (pt) Derivados de indolil pirazinona úteis para tratamento de distúrbios e doenças hiperproliferativos associados com angiogênese
BR112013028813A2 (pt) derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e seu uso no tratamento de infecções bacterianas
BR0112395A (pt) Derivados de benzotiazol
BRPI0514536A (pt) uso de oligossacarìdeos não-digerìveis e sacarìdeo de galactose digerìvel, e, composição adequada para o tratamento e/ou prevenção de infecções do trato respiratório e/ou doença de infecção do trato respiratório
CU23367A3 (es) Formulación de moxifloxacino con sal común
DE60123277D1 (de) Makrolidantibiotika
BR0012590A (pt) Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central
NO20064201L (no) Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
BR112013032974A2 (pt) "derivados de 1,6-diazabiciclo [3,2,1]-octan-7-ona, seus usos, e composições farmacêuticas".
BR122020006906B8 (pt) compostos e composições farmacêuticas antivirais
ECSP088902A (es) Derivados de pirazolo[3,4-d]-pirimidina utiles para tratar trastornos respiratorios
UA94901C2 (ru) Антибактериальные производные пиперидина
BR0116605A (pt) Composto, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo, sua utilização e processo para o tratamento e profilaxia de distúrbios do sistema nervoso central, distúrbios cardiovasculares, distúrbios gastrintestinais e apnéia do sono
BR0112571A (pt) Método para o tratamento de fêmeas humanas, composição farmaceuticamente aceitável e dispositivo para aplicação intravaginal ou transvaginal de um agente farmacêutico antifúngico, antiviral, antibacteriano ou parasiticida
BR0112750A (pt) Aminopiperidina quinolinas e seus análogos azaisostéricos com atividade antibacteriana
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
WO2007075695A3 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
NO20083250L (no) Antibakterielle pyrrolopyridiner, pyrrolopyrimidiner og pyrroloazepiner
BR0210075A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou distúrbios da debilitação intelectual e de fadiga de vÈo, cessamento de fumar, dependência de nicotina, dores, e para a colite ulcerativa
WO2006108681A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against bacteria
NO20092655L (no) 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler
WO2004039822A3 (en) 4’’ - modified erythromycin derivatives

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.